CEACAM5 and adenocarcinoma: On histopathology, the scalp tumor demonstrated an immunohistochemical profile supportive of an adenocarcinoma (pankeratin+, CEA+) with neuroendocrine differentiation (synaptophysin+) and hormonal receptor positivity (ER+, PR+, androgen receptor positivity).